YU1901A - Upotreba nab1 i nab2 u farmaciji - Google Patents
Upotreba nab1 i nab2 u farmacijiInfo
- Publication number
- YU1901A YU1901A YU1901A YU1901A YU1901A YU 1901 A YU1901 A YU 1901A YU 1901 A YU1901 A YU 1901A YU 1901 A YU1901 A YU 1901A YU 1901 A YU1901 A YU 1901A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- nab1
- nab2
- pharmaceutical uses
- polypeptides
- mammal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Ovaj pronalazak odnosi se na upotrebu, pogotovo u genskoj terapiji, NAB1 ili NAB2 polipetida ili njihovih biološki aktivnih fragmenata, i na nukleinske kiseline koje kodiraju ovakve polipeptide, u proizvodnji medikamenata za lečenje poremećaja ćelijske proleiferacije koji su povezani sa procesom zarašćivanja rana kod sisara, uključujući čoveka.[The invention relates to the use, particularly in gene therapy, of an NAB1 or NAB2 polypeptide or a biologically active fragment thereof, and to nucleic acid molecules encoding such polypeptides, in the manufacture of a medicament for the treatment of cell proliferation disorders associated with wound healing in a mammal, including human.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9814989.1A GB9814989D0 (en) | 1998-07-11 | 1998-07-11 | Gene therapy method |
| GBGB9819826.0A GB9819826D0 (en) | 1998-09-12 | 1998-09-12 | Gene therapy method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU1901A true YU1901A (sh) | 2005-06-10 |
Family
ID=26314007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU1901A YU1901A (sh) | 1998-07-11 | 1999-07-09 | Upotreba nab1 i nab2 u farmaciji |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1097200A1 (sh) |
| JP (1) | JP2002520020A (sh) |
| KR (1) | KR20010071832A (sh) |
| CN (1) | CN1317045A (sh) |
| AP (1) | AP2001002038A0 (sh) |
| AU (1) | AU763713B2 (sh) |
| BR (1) | BR9912018A (sh) |
| CA (1) | CA2336805A1 (sh) |
| EA (1) | EA200100028A1 (sh) |
| EE (1) | EE200100020A (sh) |
| HR (1) | HRP20010025A2 (sh) |
| HU (1) | HUP0102835A3 (sh) |
| ID (1) | ID27742A (sh) |
| IL (1) | IL140533A0 (sh) |
| IS (1) | IS5788A (sh) |
| NO (1) | NO20010166L (sh) |
| NZ (1) | NZ509174A (sh) |
| PL (1) | PL345507A1 (sh) |
| SK (1) | SK382001A3 (sh) |
| TR (1) | TR200100622T2 (sh) |
| WO (1) | WO2000003014A1 (sh) |
| YU (1) | YU1901A (sh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9928430D0 (en) * | 1999-12-01 | 2000-01-26 | Glaxo Group Ltd | Screening |
| AU2001291019A1 (en) | 2000-09-15 | 2002-03-26 | Genvec, Inc. | Method of modulating neovascularization |
| WO2004083435A1 (en) * | 2003-03-17 | 2004-09-30 | Julius-Maximilians-Uni Versität Würzburg | Nab proteins and their use in diagnostic and therapeutic applications in heart disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5036006A (en) * | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5697901A (en) * | 1989-12-14 | 1997-12-16 | Elof Eriksson | Gene delivery by microneedle injection |
-
1999
- 1999-07-09 PL PL99345507A patent/PL345507A1/xx not_active Application Discontinuation
- 1999-07-09 YU YU1901A patent/YU1901A/sh unknown
- 1999-07-09 SK SK38-2001A patent/SK382001A3/sk unknown
- 1999-07-09 EA EA200100028A patent/EA200100028A1/ru unknown
- 1999-07-09 CN CN99810616A patent/CN1317045A/zh active Pending
- 1999-07-09 IL IL14053399A patent/IL140533A0/xx unknown
- 1999-07-09 EP EP99931378A patent/EP1097200A1/en not_active Withdrawn
- 1999-07-09 AU AU47914/99A patent/AU763713B2/en not_active Ceased
- 1999-07-09 BR BR9912018-6A patent/BR9912018A/pt not_active IP Right Cessation
- 1999-07-09 CA CA002336805A patent/CA2336805A1/en not_active Abandoned
- 1999-07-09 TR TR2001/00622T patent/TR200100622T2/xx unknown
- 1999-07-09 HU HU0102835A patent/HUP0102835A3/hu unknown
- 1999-07-09 EE EEP200100020A patent/EE200100020A/xx unknown
- 1999-07-09 ID IDW20010345A patent/ID27742A/id unknown
- 1999-07-09 WO PCT/GB1999/002199 patent/WO2000003014A1/en not_active Application Discontinuation
- 1999-07-09 AP APAP/P/2001/002038A patent/AP2001002038A0/en unknown
- 1999-07-09 JP JP2000559235A patent/JP2002520020A/ja active Pending
- 1999-07-09 NZ NZ509174A patent/NZ509174A/en unknown
- 1999-07-09 KR KR1020017000413A patent/KR20010071832A/ko not_active Application Discontinuation
-
2000
- 2000-12-22 IS IS5788A patent/IS5788A/is unknown
-
2001
- 2001-01-10 NO NO20010166A patent/NO20010166L/no not_active Application Discontinuation
- 2001-01-11 HR HR20010025A patent/HRP20010025A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20010166D0 (no) | 2001-01-10 |
| WO2000003014A1 (en) | 2000-01-20 |
| EA200100028A1 (ru) | 2001-08-27 |
| IL140533A0 (en) | 2002-02-10 |
| HUP0102835A3 (en) | 2003-09-29 |
| AU4791499A (en) | 2000-02-01 |
| EE200100020A (et) | 2002-06-17 |
| CA2336805A1 (en) | 2000-01-20 |
| JP2002520020A (ja) | 2002-07-09 |
| NO20010166L (no) | 2001-03-06 |
| IS5788A (is) | 2000-12-22 |
| AU763713B2 (en) | 2003-07-31 |
| EP1097200A1 (en) | 2001-05-09 |
| HUP0102835A2 (hu) | 2001-11-28 |
| PL345507A1 (en) | 2001-12-17 |
| CN1317045A (zh) | 2001-10-10 |
| KR20010071832A (ko) | 2001-07-31 |
| NZ509174A (en) | 2003-08-29 |
| AP2001002038A0 (en) | 2001-03-31 |
| HRP20010025A2 (en) | 2001-12-31 |
| ID27742A (id) | 2001-04-26 |
| SK382001A3 (en) | 2001-09-11 |
| BR9912018A (pt) | 2006-01-31 |
| TR200100622T2 (tr) | 2001-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE255128T1 (de) | Peptid-immitierende substanzen in der krebstherapie | |
| NO20024157D0 (no) | Kasein-avledete peptider og anvendelser derav i terapi | |
| NZ500657A (en) | Interleukin-3 gene therapy for cancer | |
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| NZ271756A (en) | Human macrophage inflammatory proteins and coding sequences, their production and use | |
| PT698108E (pt) | Vectores adenovirais de origem animal e utilizacao em terapia genica | |
| DE3680368D1 (de) | Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate. | |
| EP0815202A4 (en) | HUMAN TISSUE INHIBITOR OF METALLOPROTEINASE-4 | |
| AP2000001999A0 (en) | Gene therapy method. | |
| WO2004034966A3 (en) | Substances for preventing and treating autoimmune diseases | |
| EP2289911A3 (en) | Therapeutic use of a growth factor, NsG33 | |
| WO2003062273A3 (en) | Modulator of the notch signalling pathway and use thereof in medical treatment | |
| NZ500427A (en) | The use of ribozyme treatment for retinal diseases | |
| AU3386100A (en) | Anti-tnfalpha antibodies in therapy of asthma | |
| ES2181710T3 (es) | Adenovirus recombinantes y su utilizacion en terapia genica para el tratamiento de las patologias oculares. | |
| IL141984A0 (en) | Akt nucleic acids, polypeptides, and uses thereof | |
| DE60015560D1 (de) | Verwendung von aminosäure zur herstellung von arzneimitteln zur behandlung von insulinresistenz | |
| YU1901A (sh) | Upotreba nab1 i nab2 u farmaciji | |
| MXPA05004973A (es) | Agentes para aliviar el dolor. | |
| EP0795332A3 (en) | Medical use of gamma-interferon in interstitial lung diseases | |
| AU6349400A (en) | Methods for treatment of hyperproliferative diseases using human mda-7 | |
| WO2002090552A3 (en) | Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing | |
| KR100488038B1 (ko) | 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도 | |
| AU2002365974A1 (en) | Alpha-fetoprotein peptides and uses thereof | |
| EP0905234A3 (en) | Allelic variant of human STAT3 |